Literature DB >> 24128054

Mucosal reactive oxygen species are required for antiviral response: role of Duox in influenza a virus infection.

Monika Strengert1, Richard Jennings, Suzel Davanture, Patti Hayes, Gülsah Gabriel, Ulla G Knaus.   

Abstract

AIMS: Influenza A virus (IAV), a major airborne pathogen, is closely associated with significant morbidity and mortality. The primary target for influenza virus replication is the respiratory epithelium, which reacts to infection by mounting a multifaceted antiviral response. A part of this mucosal host defense is the generation of reactive oxygen species (ROS) by NADPH oxidases. Duox1 and Duox2 are the main ROS-producing enzymes in the airway epithelium, but their contribution to mammalian host defense is still ill defined.
RESULTS: To gain a better understanding of Duox function in respiratory tract infections, human differentiated lung epithelial cells and an animal model were used to monitor the effect of epithelial ROS on IAV propagation. IAV infection led to coordinated up-regulation of Duox2 and Duox-mediated ROS generation. Interference with H2O2 production and ROS signaling by oxidase inhibition or H2O2 decomposition augmented IAV replication. A nuclear pool of Duox enzymes participated in the regulation of the spliceosome, which is critical for alternative splicing of viral transcripts and controls the assembly of viable virions. In vivo silencing of Duox increased the viral load on intranasal infection with 2009 pandemic H1N1 influenza virus. INNOVATION: This is the first study conclusively linking Duox NADPH oxidases with the antiviral mammalian immune response. Further, ROS generated by Duox enzymes localized adjacent to nuclear speckles altered the splicing of viral genes.
CONCLUSION: Duox-derived ROS are host protective and essential for counteracting IAV replication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24128054     DOI: 10.1089/ars.2013.5353

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  43 in total

Review 1.  Antimicrobial actions of dual oxidases and lactoperoxidase.

Authors:  Demba Sarr; Eszter Tóth; Aaron Gingerich; Balázs Rada
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

Review 2.  Dual oxidase: a novel therapeutic target in allergic disease.

Authors:  Albert van der Vliet; Karamatullah Danyal; David E Heppner
Journal:  Br J Pharmacol       Date:  2018-03-15       Impact factor: 8.739

Review 3.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

4.  Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke.

Authors:  Ana I Casas; Pamela Wm Kleikers; Eva Geuss; Friederike Langhauser; Thure Adler; Dirk H Busch; Valerie Gailus-Durner; Martin Hrabê de Angelis; Javier Egea; Manuela G Lopez; Christoph Kleinschnitz; Harald Hhw Schmidt
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 5.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

Review 6.  The complex roles of NADPH oxidases in fungal infection.

Authors:  Deborah Hogan; Robert T Wheeler
Journal:  Cell Microbiol       Date:  2014-07-07       Impact factor: 3.715

7.  Distinct functional roles of amphibian (Xenopus laevis) colony-stimulating factor-1- and interleukin-34-derived macrophages.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Leukoc Biol       Date:  2015-07-01       Impact factor: 4.962

8.  Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly.

Authors:  Sharon O'Neill; Magalie Mathis; Lidija Kovačič; Suisheng Zhang; Jürgen Reinhardt; Dimitri Scholz; Ulrich Schopfer; Rochdi Bouhelal; Ulla G Knaus
Journal:  J Biol Chem       Date:  2018-04-19       Impact factor: 5.157

Review 9.  NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.

Authors:  Yixuan Zhang; Priya Murugesan; Kai Huang; Hua Cai
Journal:  Nat Rev Cardiol       Date:  2019-10-07       Impact factor: 32.419

10.  Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus.

Authors:  Aaron Gingerich; Lan Pang; Jarod Hanson; Daniel Dlugolenski; Rebecca Streich; Eric R Lafontaine; Tamás Nagy; Ralph A Tripp; Balázs Rada
Journal:  Inflamm Res       Date:  2015-11-25       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.